Search

everythinglearnresearchcommunity

for

Search:↓

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

IL-17 and certain immune cells are linked to more severe alopecia areata.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Early intervention and patient education are crucial for managing alopecia areata.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Choosing the right method to separate skin layers is key for good skin cell research.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

taVNS reduces vitiligo symptoms in mice.

Gene network oscillations inside hair stem cells are key for hair growth regulation and could help treat hair loss.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Leflunomide is more likely to help treat alopecia areata than cause it.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.